NCT00515983
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Instituto Médico Alexander Fleming Buenos Aires, Buenos Aires F.D., Argentina
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,767 public trials
494 recruiting studies
Neuroendocrine Tumors trial results
NCT00232726
- Conditions
- Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- The Norwegian Radium Hospital Oslo, Norway
- University Hospital Lund, Sweden
NCT00083252
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- University of Arkansas Medical Sciences Little Rock, Arkansas, United States
- Cancer Institute Medical Group, Inc. Santa Monica, California, United States
- University of Colorado Health Sciences Center Aurora, Colorado, United States
- Cancer Center of Florida Ocoee, Florida, United States
Completed
Study of Talabostat in Advanced Melanoma
NCT00083239
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Chicago, Illinois, United States
- University of Michigan Ann Arbor, Michigan, United States
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT00204607
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Department of Dermatology, University of Tübingen Tübingen, Germany
NCT00441662
- Conditions
- Edema, Melanoma, Neoplasms, +12 more
- Locations
-
- Ocular Oncology Service, Wills Eye Institute Philadelphia, Pennsylvania, United States
NCT00306553
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Dept. of Dermatology, USZ Zurich, Canton of Zurich, Switzerland
- Dept. of Oncology, USZ Zurich, Canton of Zurich, Switzerland
Completed
GM-CSF as Adjuvant Therapy of Melanoma
NCT00350597
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Northern California Melanoma Center San Francisco, California, United States
NCT00237965
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
Not specified
Completed
Ultrasound Biomicroscopy - Apoptosis
NCT00188370
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +20 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada